Ozempic Face: Causes, Prevention & Best Treatments [2026]

---

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence.

---

By The GLP-1 Guide Team

---

If you have been searching "ozempic face before and after" photos online, you have already noticed something striking: the same dramatic weight loss that reshapes the body can leave the face looking hollowed, gaunt, or aged — sometimes adding years to a person's appearance even as the rest of their body gets healthier.

This is Ozempic face. It is real, it is common, and — importantly — it is largely preventable and treatable.

About 12.4% of U.S. adults now report using a GLP-1 receptor agonist for weight loss, more than double the 5.8% recorded in February 2024. Roughly one in five women aged 50 to 64 have used these medications. A systematic review published in 2025 found that 96% of all medical literature on this topic was published between 2023 and 2025, reflecting how rapidly this has become a clinical priority. And in 2026, the treatment landscape has continued to evolve — with a new radiographic study quantifying the problem for the first time, emerging research on GLP-1 receptor effects on skin cells, and a broader toolkit of regenerative approaches available to patients.

This guide breaks down the science behind why facial volume loss happens on GLP-1 medications, what it actually looks like at different stages of weight loss, and the most evidence-supported strategies for preventing and treating it. Whether you are just starting semaglutide or tirzepatide, or you are already noticing changes in your face, this article will give you the specific information you need to make informed decisions.

---

What Is Ozempic Face?

"Ozempic face" is a colloquial term — not a clinical diagnosis — used to describe the facial aging effect that can accompany rapid or significant weight loss on GLP-1 receptor agonist medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).

The term was popularized in a 2023 New York Times piece after plastic surgeons and dermatologists began reporting a surge in patients seeking facial volume restoration following GLP-1-related weight loss. It quickly entered mainstream conversation, though the phenomenon itself is not new — it has been observed in any context involving rapid fat loss, including bariatric surgery.

Clinically, Ozempic face refers to a combination of:

• Loss of subcutaneous (under-skin) fat in the cheeks, temples, and periorbital (around the eye) areas
• Increased visibility of facial bones and underlying structure
• Deepening of nasolabial folds (the lines from nose to mouth)
• Sagging or loose skin caused by volume deflation, not skin damage
• A generally hollowed or "sunken" appearance, particularly in the mid-face

The critical distinction: Ozempic face is primarily a consequence of losing body fat rapidly — fat that includes the facial fat pads that give faces a full, youthful appearance. However, emerging 2025 research suggests the mechanism may be more complex than simple fat loss (more on this below).

For a complete overview of all medication side effects, see our GLP-1 side effects guide.

---

Why Ozempic Face Happens

Understanding the mechanism helps explain why some people experience dramatic facial changes while others on the same medication see minimal effects.

The Role of Facial Fat Pads

The face contains discrete, compartmentalized fat pads — clusters of fat cells that sit beneath the skin and above the facial muscles. These fat pads are part of what gives faces their shape, volume, and youthfulness.

Key facial fat pads include:

• Malar (cheek) fat pad — provides the fullness of the mid-cheek
• Nasolabial fat pad — fills the area between the nose and mouth
• Temporal fat pad — fills the temple area on the sides of the forehead
• Buccal fat pad — gives the lower cheek its roundness
• Periorbital fat — cushions and fills the under-eye and around the orbit

When the body loses fat in response to a caloric deficit — which GLP-1 medications create by suppressing appetite and slowing gastric emptying — it draws from fat stores throughout the body, including these facial fat pads.

New Research: GLP-1 Effects on Skin Cells (2025)

A 2025 study published in PMC revealed that the aging effect may not be limited to fat loss alone. Researchers found that GLP-1 receptor agonists can act directly on adipose-derived stem cells (ADSCs) and fibroblasts — the cells responsible for producing collagen and maintaining skin structure. Specifically:

• Stimulation of the GLP-1 receptor reduces the ability of ADSCs to produce protective cytokines
• This promotes the production of reactive oxygen species (ROS), which causes oxidative damage to fibroblasts
• The result: potential acceleration of skin aging beyond what fat loss alone would cause

This is early research. But it suggests that "Ozempic face" may involve a direct drug-skin interaction in addition to volume depletion — a finding that could reshape how dermatologists approach prevention.

Why Rapid Weight Loss Accelerates the Effect

The body does not allow you to choose where it loses fat. Fat loss happens systemically, but the face is particularly vulnerable because:

1. Facial fat pads are relatively small in volume. A modest amount of fat loss across the whole body can represent a disproportionately large percentage of facial fat pad volume.
2. The face is constantly visible. Changes that might go unnoticed elsewhere are immediately apparent on the face.
3. Skin does not contract as quickly as fat depletes. When volume is lost rapidly, skin that was previously supported by fat begins to sag or fold.
4. Collagen degrades during rapid weight loss. Research published in Plastic and Reconstructive Surgery found that collagen fibers were significantly thinner in the dermis of individuals with prior massive weight loss compared to those with no weight loss history.

According to a 2021 review published in Aesthetic Surgery Journal, patients who lose weight rapidly — defined as more than 1 kg (approximately 2.2 lbs) per week — are significantly more likely to experience facial skin laxity compared to those who lose weight at a slower, more gradual rate.

Quantifying the Problem: The Radiographic Evidence

A 2025 study published in Otolaryngology–Head and Neck Surgery provided the first radiographic quantification of Ozempic face. Researchers analyzed CT scans of 20 patients on GLP-1 agonists and found:

• Median total midfacial volume decrease: 9.0%
• Superficial volume decreased by 11.0%, deep volume by 7.0%
• Linear regression showed a loss of 7% facial volume for every 10 kg of weight lost
• The relationship was strongest in superficial fat pads — the ones most visible to the naked eye
• The overall effect increased perceived facial age by an average of 2.9 years, with some patients appearing up to five years older

This is significant because it shows the volume loss is measurable and predictable. A patient losing 20 kg on semaglutide or tirzepatide can expect roughly 14% midfacial volume loss — enough to visibly age the face.

The Scale of the Problem

Clinical trials provide the context for why this is so common among GLP-1 users:

• Semaglutide (STEP 1 trial, 2021): participants lost an average of 14.9% of body weight over 68 weeks, with extended use resulting in 17.3% sustained weight loss
• Tirzepatide (SURMOUNT-1 trial, 2022): participants achieved an average weight reduction of 20.9% at the highest dose
• 25-40% of weight lost on GLP-1 medications is lean muscle mass, which affects facial structure
• Patients with massive weight loss appeared approximately 5.1 years older than their actual age upon blinded clinical evaluation

A multi-center experience-based guidance study involving approximately 250 patients actively losing weight and 150+ post-weight-loss patients documented consistent patterns of midface volume loss, temple hollowing, submalar hollowing, increased skin laxity, and platysma band exposure in the neck.

Who Is Most Affected?

Not everyone on a GLP-1 will develop noticeable facial changes. Risk factors include:

• Higher total weight loss: Patients who lose more than 15% of body weight are at significantly higher risk
• Rapid rate of loss: Losing more than 2 pounds per week accelerates facial volume depletion
• Age over 40: Less resilient collagen and reduced skin elasticity mean less recovery capacity
• Lower baseline facial fat: Patients who started with leaner faces have less margin before hollowing becomes noticeable
• Smoking history: Nicotine damages collagen production, compounding the effect
• Inadequate protein intake: Patients not consuming the recommended minimum of 0.8 g/kg daily protein lose more lean mass, including facial muscle

---

Before and After: What Ozempic Face Looks Like

This section describes the typical progression of Ozempic face through different stages of weight loss on GLP-1 therapy.

Early-Stage Weight Loss (Less Than 5% Body Weight Lost)

At this stage, most people notice little to no facial change. The body is drawing from glycogen stores and distributing early fat loss broadly. Some patients report their face looking "slimmer" in a flattering way — cheekbones becoming more defined, facial contours sharpening.

What you might notice:

• Reduced puffiness (particularly if starting weight included facial bloating)
• Slightly more defined jawline
• Collar and neck area appearing slimmer

Mid-Stage Weight Loss (5-15% Body Weight Lost)

This is where the change begins to look like what most people describe as "Ozempic face." The mid-face starts losing volume more visibly.

What you might notice:

• Cheeks appearing flatter or hollowed
• More prominent cheekbones (at first perceived as flattering, later concerning)
• Deepening lines from the nose to the corners of the mouth
• Under-eye hollowing or "tear trough" becoming more visible
• Temples appearing slightly sunken

Advanced-Stage Weight Loss (More Than 15% Body Weight Lost)

At this stage — which aligns with the average results seen in GLP-1 clinical trials — facial aging effects are often most pronounced.

What you might notice:

• Significantly hollowed cheeks
• Jowling (skin sagging along the jawline due to volume deflation)
• Deep nasolabial folds
• Hollow or concave temporal areas
• Under-eye bags appearing more pronounced as fat support diminishes
• Skin appearing loosely draped rather than smooth

It is worth emphasizing: these changes reflect the face looking aged, not unhealthy. Many patients simultaneously feel healthier, have improved metabolic markers, and have more energy.

---

Prevention: 4 Strategies That Actually Work

Preventing Ozempic face does not mean avoiding weight loss — it means managing how you lose weight and supporting your skin and facial tissue throughout the process.

1. Slow Your Rate of Weight Loss

This is the single most impactful prevention strategy. The faster fat is depleted, the less time skin has to adapt. Given the new radiographic data showing 7% volume loss per 10 kg, slowing total weight loss directly reduces the severity of facial changes.

Practical steps:

• Work with your prescribing provider to titrate your dose conservatively
• Target a loss of 1-2 lbs per week, not more
• If you are losing weight faster than that on your current dose, discuss dose reduction or meal adjustments
• Track your weight weekly to identify trends

According to the American Academy of Dermatology, gradual weight loss of 0.5-1 kg per week is associated with significantly better skin outcomes compared to rapid loss.

2. Prioritize Protein Intake

One of the underappreciated consequences of GLP-1-related appetite suppression is that patients often reduce total caloric intake dramatically — sometimes below 1,000 calories per day. Without adequate protein, the body breaks down muscle tissue for energy, accelerating facial hollowing.

Evidence-based protein targets:

• 1.6-2.2 grams of protein per kilogram of body weight per day (International Society of Sports Nutrition recommendation for lean mass preservation during caloric restriction)
• Prioritize complete protein sources: eggs, poultry, fish, Greek yogurt, cottage cheese, legumes
• Consider a daily protein shake if hitting your target is difficult on a reduced appetite

For a comprehensive dietary strategy, see our GLP-1 diet guide.

3. Start Resistance Training

Muscle mass provides structural support beneath the skin. A 2022 study published in Obesity Reviews found that combining resistance exercise with caloric restriction preserved approximately 27% more lean mass compared to caloric restriction alone.

Getting started:

• Two to three resistance training sessions per week is sufficient
• Bodyweight exercises (push-ups, squats, rows) are accessible without gym access
• Focus on compound movements that engage large muscle groups

For a complete exercise protocol, see our guide on preventing muscle loss on GLP-1 medications.

4. Proactive Skin Care

While no topical product can prevent facial volume loss, certain ingredients stimulate collagen production and improve skin elasticity — especially important given the 2025 findings about GLP-1 effects on fibroblasts:

• Retinoids (retinol, tretinoin): Stimulate collagen synthesis and accelerate skin cell turnover. A 2019 review in Dermatology and Therapy found tretinoin significantly improved skin elasticity.
• Vitamin C (L-ascorbic acid at 10-20%): Supports collagen synthesis and protects against oxidative damage. Particularly relevant given new evidence that GLP-1 agonists may increase ROS production in skin cells.
• Niacinamide (vitamin B3): Strengthens the skin barrier and supports collagen production — now recommended by dermatologists as part of the standard GLP-1 skincare protocol.
• SPF 30+ daily: UV exposure accelerates collagen breakdown — non-negotiable during weight loss.
• Hydration: GLP-1 medications can cause dehydration. Aim for 2-3 liters of water daily.

---

Treatment Options: From Fillers to Regenerative Therapies [2026 Update]

The treatment landscape for Ozempic face has evolved significantly. In 2026, the most effective approaches combine immediate volume restoration with regenerative therapies that rebuild skin quality from within. Practitioners who have treated 250+ GLP-1 patients recommend a multimodal approach rather than relying on any single treatment.

The American Society of Plastic Surgeons reported approximately 1.6 million cosmetic surgical procedures in the U.S. in 2025, with body contouring among the fastest-growing categories — driven substantially by GLP-1 patients.

Dermal Fillers (First-Line for Immediate Volume)

Dermal fillers remain the most common and immediately effective treatment for Ozempic face.

Types of fillers for GLP-1 facial volume loss:

• Hyaluronic acid fillers (Juvederm Voluma, Restylane Lyft): Immediate volume restoration, reversible, lasting 12-24 months. Best for cheeks, under-eyes, and nasolabial folds. Use medium-to-high G' formulations for structural lift. Cost: $800-$1,200 per syringe in 2026, with Voluma at the higher end.
• Poly-L-lactic acid (Sculptra): Gradual collagen stimulation over 2-4 months, lasting 2+ years. Requires 2-3 sessions. A multi-center study found that poly-L-lactic acid provided particularly long-lasting results in GLP-1 patients due to its collagen and elastin regeneration properties. Cost: $800-$1,200 per vial.
• Calcium hydroxylapatite (Radiesse): Both volume and collagen stimulation. Lasts 12-18 months. Not reversible. Cost: $750-$1,100 per syringe.

Total treatment cost: Most patients need 2-4 syringes of HA filler + 2-3 vials of biostimulator. Full treatment: $3,200-$7,500 in 2026, up slightly from 2025 due to increased demand from GLP-1 patients.

Exosome Therapy + RF Microneedling (Best Regenerative Option)

This combination remains one of the most significant advancements in Ozempic face treatment. Exosome therapy — using concentrated growth factors, peptides, and signaling molecules derived from stem cells — combined with radiofrequency microneedling directly addresses the collagen thinning documented in weight-loss patients.

Clinical evidence: A split-face randomized trial comparing adipose mesenchymal stem cell-derived exosomes to PRP (both combined with RF microneedling) found:

• 37% improvement in photoaging scores at 3 months on the exosome side
• Both treatments equally improved wrinkling, dyschromia, texture, and overall skin appearance
• Histological biopsies confirmed increased collagen I and glycosaminoglycans in treated skin
• No adverse events reported
• Exosomes eliminated the need for a blood draw, reducing office visit time

A 2026 narrative review in Biomedicines synthesized dermatologic applications of exosomes reported between 2020 and 2025, confirming improvements in hydration, elasticity, and pigmentation when combined with microneedling — with benefits evident by six weeks.

The combination works because RF microneedling creates controlled micro-injuries and delivers thermal energy deep into the dermis, while exosomes flood those channels with regenerative molecules that accelerate collagen remodeling.

Important FDA note: No exosome products are currently FDA-approved for therapeutic use in humans. The FDA has continued enforcement actions against manufacturers making unsubstantiated claims. When seeking exosome therapy, verify your provider uses products from registered facilities and understands the regulatory landscape.

What to expect: 3 sessions spaced 4 weeks apart. Results begin around week 3, with continued improvement for 3-6 months. Minimal downtime (1-3 days of redness). Results last 12-18 months.

Cost: $1,200-$2,500 per session. Full protocol: $3,600-$7,500.

Subdermal Bipolar Radiofrequency (New for 2025-2026)

A 2025 study published in the Journal of Clinical Medicine evaluated endotissutal bipolar radiofrequency as a treatment specifically for Ozempic face. The case series of 24 patients (19 women, 5 men, ages 27-65) treated between 2023 and 2024 found:

• High satisfaction levels (8+ out of 10) in the majority of patients
• Results correlated with independent expert evaluation
• Promotes long-term skin rejuvenation through neocollagenesis (new collagen formation)
• Only adverse event was transient redness
• Minimum 12-month follow-up confirmed result stability

This is a newer modality worth discussing with your provider — particularly for patients who want skin tightening without fillers. It targets the deeper tissue layers and promotes structural collagen rebuilding rather than surface-level changes.

PRP/PRF Therapy (Budget Regenerative Alternative)

Platelet-Rich Plasma therapy uses your own blood — drawn, centrifuged, and concentrated — to deliver growth factors into facial skin. The same split-face trial showed PRP performed comparably to exosomes, with no statistically significant differences in clinical outcomes.

The trade-off: PRP requires a blood draw and centrifugation (20-30 minutes extra), while exosomes are ready to apply immediately. PRP is typically less expensive per session.

Cost: $600-$1,500 per session. Full protocol (3 sessions): $1,800-$4,500.

RF Microneedling Alone (Best for Skin Tightening)

RF microneedling (Morpheus8, Genius RF, Potenza) combines traditional microneedling with radiofrequency energy to stimulate deep collagen remodeling. It addresses the skin laxity component — tightening loose skin along the jawline and improving texture — though it does not restore lost volume.

Morpheus8 carries an 87% satisfaction rate on RealSelf, with results lasting 12-18 months.

What to expect: 1-3 sessions spaced 4-6 weeks apart. Improvement starts around week 3, continues for 3-6 months. Results last 1-2 years.

Cost: $700-$1,500 per session for face treatments in 2026. Full protocol (3 sessions): $2,100-$4,500. Many clinics offer 10-20% discounts for committing to a full series upfront.

Fat Transfer (Best for Severe Volume Loss)

For patients with significant facial volume loss — typically those who have lost 30+ pounds — autologous fat transfer is the most comprehensive surgical solution. The American Academy of Facial Plastic and Reconstructive Surgery reported a 50% increase in facial fat grafting procedures in 2024, driven significantly by GLP-1 patients. That trend has continued into 2025 and 2026.

Fat transfer delivers a dual benefit that no filler can match: long-lasting structural restoration plus regenerative effects from the fat's natural stem cell population. A newer technique called nanofat transfer uses emulsified microfat (particles smaller than 0.1 mm) containing high concentrations of stem cells and growth factors, improving skin quality — thickness, brightness, texture — on top of volume.

What to expect: Single procedure, 60-70% of transferred fat survives long-term, significant swelling for 1-2 weeks, full results at 3-6 months. Results are semi-permanent (5+ years).

Cost: $4,500-$10,000+ depending on extent and location. Average reported cost on RealSelf: approximately $7,000.

Facelift Surgery (Last Resort for Severe Laxity)

In cases of extreme skin laxity — particularly in patients who have lost very large amounts of weight — surgical skin removal may be the most effective option. This is typically a last resort after non-surgical options have been explored.

Cost: $8,000-$20,000+. Recovery: 2-4 weeks.

---

Treatment Comparison Table

Treatment	Volume Restoration	Skin Tightening	Collagen Boost	Cost (Full Protocol)	Duration
HA Fillers + Biostimulators	Very High	Low	Moderate	$3,200-$7,500	9 months - 2+ years
Exosome + RF Microneedling	Moderate	High	Very High	$3,600-$7,500	12-18 months
Subdermal Bipolar RF	Low-Moderate	High	High	$2,000-$5,000	12+ months
PRP + Microneedling	Low-Moderate	Moderate	High	$1,800-$4,500	9-12 months
RF Microneedling Alone	Low	High	High	$2,100-$4,500	1-2 years
Fat Transfer (Surgical)	Very High	Low	Moderate	$4,500-$10,000+	5+ years
Facelift	None (removes excess)	Very High	None	$8,000-$20,000+	5-10+ years

---

The Optimal Combination Protocol

Most aesthetic practitioners who specialize in GLP-1 patients now recommend a multimodal approach:

1. Phase 1 (Weeks 1-4): Dermal fillers for immediate volume + biostimulator to begin collagen production
2. Phase 2 (Weeks 4-12): Exosome facial or PRP combined with RF microneedling — 3 sessions for skin quality and tightening
3. Phase 3 (Months 4-6): Touch-up filler if needed, additional biostimulator session
4. Maintenance: At-home skincare routine (retinoid, vitamin C, niacinamide, SPF), annual RF microneedling, filler touch-ups every 12-18 months

This multimodal approach has shown 90-95% patient satisfaction when all phases are completed.

---

Frequently Asked Questions

Does everyone who takes Ozempic or Wegovy get Ozempic face?

No. Not everyone who uses GLP-1 medications will experience significant facial volume loss. The 2025 radiographic study showed a predictable relationship — about 7% midfacial volume loss per 10 kg of weight lost — but the visible impact varies widely depending on age, baseline facial fat, skin elasticity, and rate of loss. Younger patients and those who lose weight gradually are considerably less likely to develop noticeable facial aging effects.

How long does it take for Ozempic face to appear?

Most patients who experience noticeable facial changes report observing them after losing 10-20 lbs or more — typically within the first 3-6 months of treatment at therapeutic doses. The effect is cumulative: the more weight lost, the more pronounced the changes. The radiographic data confirms that superficial fat pads (the visible ones) are disproportionately affected.

Can you reverse Ozempic face without cosmetic procedures?

Mild cases may partially improve if weight loss is slowed or if the patient regains a modest amount of weight. However, once significant facial fat pad depletion has occurred, the body does not selectively restore fat to the face during weight regain. For clinically noticeable hollowing, dermal fillers and regenerative treatments are the most effective and predictable reversal strategies.

What is the difference between exosomes and PRP for treating Ozempic face?

A head-to-head clinical trial found no statistically significant differences in outcomes between exosome therapy and PRP when both were combined with RF microneedling. Both equally improved skin quality, wrinkles, and texture. The practical differences: exosomes require no blood draw (faster, no needle for phlebotomy-averse patients) but are not FDA-approved and cost more per session. PRP uses your own biological material, is typically less expensive ($600-$1,500 vs $1,200-$2,500 per session), and has a longer track record. Both are considered safe with no adverse events reported in clinical trials.

Should I wait until I reach my target weight before getting treatment?

It depends on the treatment type. Fillers: most practitioners recommend waiting until weight is relatively stable, as continued loss can shift filler placement. Regenerative treatments (exosomes, PRP, RF microneedling): these can be started during active weight loss as preventive measures. Stimulating collagen production while your face is adapting helps maintain skin quality and minimize the severity of future volume loss.

Does the GLP-1 drug itself damage my skin?

Early research from 2025 suggests it might, at least indirectly. A study found that GLP-1 receptor agonists can reduce the ability of adipose-derived stem cells to produce protective cytokines, promoting oxidative damage to fibroblasts (the cells that produce collagen). This is still preliminary — more research is needed — but it provides another reason to invest in collagen-supporting skincare (retinoids, vitamin C, antioxidants) while on these medications.

---

Methodology / Sources

Key sources reviewed:

• STEP 1 Trial (2021): Wilding JPH, et al. The New England Journal of Medicine, 384(11), 989-1002. Average weight reduction of 14.9% over 68 weeks.
• SURMOUNT-1 Trial (2022): Jastreboff AM, et al. The New England Journal of Medicine, 387(3), 205-216. Average weight reduction of 20.9% at highest tirzepatide dose.
• Radiographic Midfacial Volume Changes in GLP-1 Patients (2025): Sharma et al. Otolaryngology–Head and Neck Surgery. 9% median midfacial volume loss; 7% per 10 kg weight lost.
• GLP-1RA and Possible Skin Aging (2025): PMC12370548. GLP-1 effects on ADSCs, fibroblast oxidative damage, and cytokine disruption.
• Systematic Review of "Ozempic Face" in Plastic Surgery (2025): PMC12232544. 23 articles reviewed; 13% of US adults have used GLP-1 agonists.
• Nonsurgical Aesthetic Treatment of GLP-1 Patients (2025): PMC12937588. Experience-based guidance from practitioners treating 250+ GLP-1 patients.
• Exosomes vs PRP Split-Face Trial (2025): PMC12104007. 37% improvement in photoaging scores; no significant differences between treatments.
• Endotissutal Bipolar RF for Ozempic Face (2025): Journal of Clinical Medicine, 14(15), 5269. 24-patient case series, high satisfaction, 12-month follow-up.
• Exosome-Based Therapeutics Narrative Review (2026): Biomedicines, 14(2), 338. Comprehensive synthesis of 2020-2025 clinical evidence.
• GLP-1 Usage Statistics (2026): Pew Research Center; CDC NCHS Data Brief 537; KFF survey data. 12.4% of U.S. adults using GLP-1 RAs for weight loss.
• ASPS Procedural Statistics (2025): 1.6 million cosmetic procedures; body contouring fastest-growing category.
• Filler Pricing Data (2026): Aggregated from RealSelf, multiple medspa price surveys. HA fillers $800-$1,200/syringe; Sculptra $800-$1,200/vial.
• Facial Aging and Weight Loss: Rohrich RJ, et al. "The Anatomical Basis of Facial Aging." Plastic and Reconstructive Surgery, 2008.
• Resistance Training and Lean Mass Preservation: Obesity Reviews, 2022. Exercise group retained 27% more lean mass.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan.

Affiliate Disclosure: We may earn a commission if you sign up for services through our links. This does not affect our editorial independence.

---

Related Reading

• GLP-1 Side Effects: Full Guide & Management Tips
• Prevent Muscle Loss on GLP-1: Evidence Protocol
• GLP-1 Diet: What to Eat on Ozempic & Mounjaro
• Semaglutide vs Tirzepatide: Complete Comparison

-- The GLP-1 Guide Team